These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24265920)

  • 1. The cytology and DNA detection by the PapilloCheck(®) test in the diagnosis of human papillomavirus infection.
    Vieira L; Almeida A
    Eur J Microbiol Immunol (Bp); 2013 Mar; 3(1):61-7. PubMed ID: 24265920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes.
    Didelot MN; Boulle N; Damay A; Costes V; Segondy M
    J Med Virol; 2011 Aug; 83(8):1377-82. PubMed ID: 21678441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia.
    Crosbie EJ; Bailey A; Sargent A; Gilham C; Peto J; Kitchener HC
    J Clin Microbiol; 2015 Nov; 53(11):3553-9. PubMed ID: 26338859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
    Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
    J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR-RFLP assay as an option for primary HPV test.
    Golfetto L; Alves EV; Martins TR; Sincero TCM; Castro JBS; Dannebrock C; Oliveira JG; Levi JE; Onofre ASC; Bazzo ML
    Braz J Med Biol Res; 2018 Mar; 51(5):e7098. PubMed ID: 29590262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
    Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
    PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and incidence of atypical glandular lesions in cervical cytology focusing on the association with high-risk human papillomavirus subtypes.
    Abbas M; De Jonge J; Bettendorf O
    Oncol Lett; 2023 Jan; 25(1):6. PubMed ID: 36419751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Head-to-Head Analytical Comparison of Cobas 4800 HPV, PapilloCheck HPV Screening, and LMNX Genotyping Kit HPV GP for Detection of Human Papillomavirus DNA in Cervical and Cervicovaginal Swabs.
    Jaworek H; Koudelakova V; Drabek J; Vrbkova J; Zborilova B; Oborna I; Brezinova J; Marek R; Huml K; Vanek P; Hajduch M
    J Mol Diagn; 2018 Nov; 20(6):849-858. PubMed ID: 30165205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data.
    Martins TR; Mendes de Oliveira C; Rosa LR; de Campos Centrone C; Rodrigues CL; Villa LL; Levi JE
    Virol J; 2016 Aug; 13():138. PubMed ID: 27515763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 test.
    Schopp B; Holz B; Zago M; Stubenrauch F; Petry KU; Kjaer SK; Iftner T
    J Med Virol; 2010 Apr; 82(4):605-15. PubMed ID: 20166179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papillomavirus negative but dyskaryotic cervical cytology: re-analysis of molecular testing.
    Peevor R; Bowden S; Jones J; Fiander AN; Hibbitts S
    J Clin Virol; 2009 Apr; 44(4):322-4. PubMed ID: 19264544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening.
    Hesselink AT; Heideman DA; Berkhof J; Topal F; Pol RP; Meijer CJ; Snijders PJ
    J Clin Microbiol; 2010 Mar; 48(3):797-801. PubMed ID: 20042622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of human papillomavirus typing for detection of anal cytological abnormalities.
    Maia LB; Marinho LC; Barbosa TW; Velasco LF; Costa PG; Carneiro FP; de Oliveira PG
    Indian J Sex Transm Dis AIDS; 2013 Jul; 34(2):102-6. PubMed ID: 24339460
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.